Literature DB >> 30036180

Experience with RHD*weak D type 4.0 in the USA.

Connie M Westhoff1, Sandra Nance2, Christine Lomas-Francis1, Margaret Keller2, Stella T Chou3.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 30036180      PMCID： PMC6476735          DOI： 10.2450/2018.0114-18

Source DB:  PubMed          Journal:  Blood Transfus        ISSN： 1723-2007            Impact factor:   3.443


× No keyword cloud information.
  4 in total

1.  Transfusion support during childbirth for a woman with anti-U and the RHD*weak D type 4.0 allele.

Authors:  Q Yin; K Srivastava; D G Brust; W A Flegel
Journal:  Immunohematology       Date:  2021-03

2.  What constitutes the most cautious approach for a pregnant person with weak D type 4.0?

Authors:  Willy Albert Flegel; Melanie Bodnar; Gwen Clarke; Judith Hannon; Lani Lieberman
Journal:  CMAJ       Date:  2021-06-14       Impact factor: 8.262

3.  Proceed with care: the "uncommon" serologic weak D phenotypes.

Authors:  Willy Albert Flegel
Journal:  Blood Transfus       Date:  2021-07       Impact factor: 3.443

4.  It's time to phase out "serologic weak D phenotype" and resolve D types with RHD genotyping including weak D type 4.

Authors:  Willy A Flegel; Gregory A Denomme; John T Queenan; Susan T Johnson; Margaret A Keller; Connie M Westhoff; Louis M Katz; Meghan Delaney; Ralph R Vassallo; Clayton D Simon; S Gerald Sandler
Journal:  Transfusion       Date:  2020-03-12       Impact factor: 3.337
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.